These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22350794)

  • 1. Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interaction.
    Lee YJ; Lee HJ; Choi SH; Jin YB; An HJ; Kang JH; Yoon SS; Lee YS
    Angiogenesis; 2012 Jun; 15(2):229-42. PubMed ID: 22350794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMP9 processing of HSPB1 regulates tumor progression.
    Choi SH; Lee HJ; Jin YB; Jang J; Kang GY; Lee M; Kim CH; Kim J; Yoon SS; Lee YS; Lee YJ
    PLoS One; 2014; 9(1):e85509. PubMed ID: 24465581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathway.
    Kumar B; Chile SA; Ray KB; Reddy GE; Addepalli MK; Kumar AS; Ramana V; Rajagopal V
    Angiogenesis; 2011 Sep; 14(3):371-80. PubMed ID: 21698469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.
    Zimmerman MW; McQueeney KE; Isenberg JS; Pitt BR; Wasserloos KA; Homanics GE; Lazo JS
    J Biol Chem; 2014 Feb; 289(9):5904-13. PubMed ID: 24403062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
    Isowa S; Shimo T; Ibaragi S; Kurio N; Okui T; Matsubara K; Hassan NM; Kishimoto K; Sasaki A
    Anticancer Res; 2010 Jul; 30(7):2755-67. PubMed ID: 20683010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis.
    Yen L; You XL; Al Moustafa AE; Batist G; Hynes NE; Mader S; Meloche S; Alaoui-Jamali MA
    Oncogene; 2000 Jul; 19(31):3460-9. PubMed ID: 10918604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
    Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process.
    Barbera-Guillem E; Nyhus JK; Wolford CC; Friece CR; Sampsel JW
    Cancer Res; 2002 Dec; 62(23):7042-9. PubMed ID: 12460925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor activation of sterol regulatory element binding protein: a potential role in angiogenesis.
    Zhou RH; Yao M; Lee TS; Zhu Y; Martins-Green M; Shyy JY
    Circ Res; 2004 Sep; 95(5):471-8. PubMed ID: 15271857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
    Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
    Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
    Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M
    Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor and soluble FLT-1 receptor interactions and biological implications.
    Malecki M; Trembacz H; Szaniawska B; Przybyszewska M; Janik P
    Oncol Rep; 2005 Dec; 14(6):1565-9. PubMed ID: 16273257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.